Please check your internet connection and try again.
# Diadzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains three active ingredients: Diadzein, Genistein, and Palmitoylethanolamide (PEA). Diadzein and Genistein are isoflavones found in soybeans, often marketed for menopausal symptom relief and general well-being. Palmitoylethanolamide is an endogenous fatty acid amide involved in pain and inflammatory modulation. The specific therapeutic use and efficacy of this combination are not well-established in rigorous clinical trials.
## Primary Indications
* **Menopausal Symptom Relief:** Primarily for hot flashes and vaginal dryness.
* **Pain and Inflammation:** PEA component may contribute to pain and inflammatory relief, though evidence for this specific combination is limited.
## Adult Dosing
Dosing varies significantly based on product formulation and intended use. A common regimen in over-the-counter products is:
* **Diadzein & Genistein:** Typically 40-60 mg total daily, often divided.
* **Palmitoylethanolamide (PEA):** Doses range from 300 mg to 1200 mg daily, often divided.
Specific dosing for this combination product should follow manufacturer's recommendations or prescriber guidance, as clinical trial data is scarce.
## Pediatric Dosing
There is no established pediatric dosing for this combination. Use in pediatric populations is not recommended due to lack of safety and efficacy data.
## Dose Adjustments
No specific dose adjustments for renal or hepatic impairment are established. Due to the lack of robust clinical data, cautious use is advised in patients with significant organ dysfunction.
## Contraindications
* Hypersensitivity to any component of the formulation.
* Pregnancy and breastfeeding (due to lack of safety data and potential hormonal effects of isoflavones).
## Adverse Effects
* **Diadzein & Genistein:** Gastrointestinal upset (nausea, bloating), potential for hormonal effects (e.g., menstrual irregularities, breast tenderness) in sensitive individuals.
* **Palmitoylethanolamide (PEA):** Generally well-tolerated. May cause mild gastrointestinal upset.
## Key Drug Interactions
* **Hormone Therapies:** Isoflavones may interact with hormone replacement therapies or oral contraceptives; consult a healthcare provider.
* **Anticoagulants/Antiplatelets:** Theoretical concern for increased bleeding risk due to potential antiplatelet effects of isoflavones, although not well-documented.
* **Tamoxifen:** Isoflavones may have weak estrogenic or anti-estrogenic effects that could interfere with tamoxifen therapy.
## Monitoring
* Monitor for effectiveness in symptom relief.
* Observe for any adverse effects, particularly gastrointestinal upset or hormonal symptoms.
* For PEA, monitor for pain and inflammation reduction.
## Clinical Pearls
* The efficacy of isoflavones for menopausal symptoms is variable and less potent than conventional hormone therapy.
* Palmitoylethanolamide is often used as an adjunct therapy for pain and inflammation.
* Due to limited rigorous clinical trials, this combination should be considered a dietary supplement or adjunct therapy rather than a primary pharmaceutical agent.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant literature before making clinical decisions.*
